MarketPeel
EVP R&D, Chief Medical Officer
Thu, Jan 30, 2025
Jan 30
exercised or converted securities in ALKS
18,345 shares @ $26.82
Increased holdings by +14.50%
Net across this filing: -6.90% (-3,286 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback